Biofrontera Warrants Total Debt vs. Total Asset
| BFRIW Stock | USD 0.13 0.05 64.77% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.54 | 0.488 |
|
|
For Biofrontera Warrants profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biofrontera Warrants to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biofrontera Warrants utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biofrontera Warrants's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biofrontera Warrants over time as well as its relative position and ranking within its peers.
Biofrontera |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera Warrants. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera Warrants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.30) | Revenue Per Share 11.573 | Quarterly Revenue Growth 0.34 | Return On Assets (0.40) | Return On Equity (1.49) |
The market value of Biofrontera Warrants is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera Warrants' value that differs from its market value or its book value, called intrinsic value, which is Biofrontera Warrants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera Warrants' market value can be influenced by many factors that don't directly affect Biofrontera Warrants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera Warrants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera Warrants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera Warrants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Biofrontera Warrants Total Asset vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biofrontera Warrants's current stock value. Our valuation model uses many indicators to compare Biofrontera Warrants value to that of its competitors to determine the firm's financial worth. Biofrontera Warrants is rated second in total debt category among its peers. It is rated fifth in total asset category among its peers fabricating about 5.17 of Total Asset per Total Debt. At this time, Biofrontera Warrants' Total Assets are fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biofrontera Warrants by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biofrontera Total Debt vs. Competition
Biofrontera Warrants is rated second in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 219.99 Million. Biofrontera Warrants holds roughly 5.4 Million in total debt claiming about 2.45% of equities under Health Care industry.
Biofrontera Total Asset vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Biofrontera Warrants |
| = | 5.4 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Biofrontera Warrants |
| = | 27.93 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Biofrontera Total Asset Comparison
Biofrontera Warrants is currently under evaluation in total asset category among its peers.
Biofrontera Warrants Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biofrontera Warrants, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biofrontera Warrants will eventually generate negative long term returns. The profitability progress is the general direction of Biofrontera Warrants' change in net profit over the period of time. It can combine multiple indicators of Biofrontera Warrants, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -291 K | -305.6 K | |
| Interest Income | 168 K | 90.6 K | |
| Operating Income | -22.7 M | -23.8 M | |
| Net Loss | -26.4 M | -27.8 M | |
| Income Before Tax | -20.1 M | -21.1 M | |
| Total Other Income Expense Net | 2.6 M | 2.1 M | |
| Net Loss | -20.1 M | -21.1 M | |
| Income Tax Expense | 14 K | 13.3 K | |
| Net Loss | (13.02) | (13.67) | |
| Income Quality | 1.24 | 1.17 | |
| Net Income Per E B T | 1.00 | 0.81 |
Biofrontera Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biofrontera Warrants. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biofrontera Warrants position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biofrontera Warrants' important profitability drivers and their relationship over time.
Use Biofrontera Warrants in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofrontera Warrants position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera Warrants will appreciate offsetting losses from the drop in the long position's value.Biofrontera Warrants Pair Trading
Biofrontera Warrants Pair Trading Analysis
The ability to find closely correlated positions to Biofrontera Warrants could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biofrontera Warrants when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biofrontera Warrants - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biofrontera Warrants to buy it.
The correlation of Biofrontera Warrants is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biofrontera Warrants moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biofrontera Warrants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biofrontera Warrants can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Biofrontera Warrants position
In addition to having Biofrontera Warrants in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.